Przejdź do zawartości
Merck

Assessment of the nail penetration of antifungal agents, with different physico-chemical properties.

PloS one (2020-02-29)
Heather Davies-Strickleton, Julie Cook, Sally Hannam, Rhys Bennett, Alan Gibbs, David Edwards, Christine Ridden, John Ridden, David Cook
ABSTRAKT

Onychomycosis, or fungal nail infection, is a common fungal infection largely caused by dermatophyte fungi, such as Trichophyton rubrum or Trichophyton mentagrophytes, which affects a significant number of people. Treatment is either through oral antifungal medicines, which are efficacious but have significant safety concerns, or with topical antifungal treatments that require long treatment regimens and have only limited efficacy. Thus, an efficacious topical therapy remains an unmet medical need. Among the barriers to topical delivery through the nail are the physico-chemical properties of the antifungal drugs. Here, we explore the ability of a range of antifungal compounds with different hydrophilicities to penetrate the nail. Human nail discs were clamped within static diffusion (Franz) cells and dosed with equimolar concentrations of antifungal drugs. Using LC-MS/MS we quantified the amount of drug that passed through the nail disc and that which remained associated with the nail. Our data identified increased drug flux through the nail for the more hydrophilic compounds (caffeine as a hydrophilic control and fluconazole, with LogP -0.07 and 0.5, respectively), while less hydrophilic efinaconazole, amorolfine and terbinafine (LogP 2.7, 5.6 and 5.9 respectively) had much lower flux through the nail. On the other hand, hydrophilicity alone did not account for the amount of drug associated with/bound to the nail itself. While there are other factors that are likely to combine to dictate nail penetration, this work supports earlier studies that implicate compound hydrophilicity as a critical factor for nail penetration.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Supelco
Fenpropimorph, PESTANAL®, analytical standard
Supelco
Flutriafol, PESTANAL®, analytical standard
Sigma-Aldrich
Efinaconazole, ≥98% (HPLC)